CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
GLP-1s
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Radiation Oncology
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
Contributors
From the Editors
Drug Pipeline
Drugs to Watch: Anticipated Q4 2023 Launches
The drug pipeline continues to flow. See what new therapies are expected to launch in the fourth quarter of 2023.
More
Briefing
Drug Pipeline
Increasing Provider Understanding of Biosimilars with Proactive Outreach
Increasing Provider Understanding of Biosimilars with Proactive Outreach
More
Briefing
Cost Management
A Balanced Approach to Weight Management Drugs
Strategies for balancing coverage and spend for high-cost diabetes and obesity medications
More
Briefing
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline
More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars
More
Briefing
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health
More
Commentary
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors
More
Commentary
Specialty
Member Experience: A Specialty Patient’s Journey
Member Experience: A Specialty Patient’s Journey
More
Briefing
Load more